VEGFA and age-related macular degeneration: In addition to its immunosuppressive qualities, sirolimus has demonstrated anti-angiogenic properties due to mTOR’s role in the VEGF cascade, prompting a pilot study investigating the use of sirolimus for persistent, exudative AMD [7, 8].